Search: 
You do not have permission to access this chart.
Please Sign Up or Login
News for Tenax Therapeutics, Inc. (TENX)
Newly released Crypto mining rig for Tenax Therapeutics, Inc. coins
minutes ago | Banggood.com
Everything Crypto on sale now!
58 minutes ago | Aliexpress.com
Tenax Announces New Publication Highlighting Novel Levosimendan Mechanism of Action in Pulmonary Hypertension Patients with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)
3 days ago | Business Wire
Tenax Therapeutics Announced KOL Webinar on Levosimendan for Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
a week ago | Business Wire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Tenax Therapeutics, Inc - TENX
a month ago | Newsfile Corp
Tenax Therapeutics Announces CEO Transition and $10 Million PIPE Offering Priced At-the-Market under Nasdaq Rules
a month ago | Business Wire
TENX Stock Price Increases Over 12% Pre-Market: Why It Happened
a month ago | Pulse2
Tenax Therapeutics Set to Join Russell Microcap® Index
2 months ago | Business Wire
Tenax Therapeutics Reports First Quarter 2021 Results and Provides Business Update
2 months ago | Business Wire
Tenax Therapeutics Stock Price Increased Over 35% Intraday: Why It Happened
4 months ago | Pulse2
Tenax Announces Publication Titled “Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial ”
4 months ago | Business Wire
Tenax Therapeutics Announces Continuation of Board Refreshment Program as Three Long-Serving Directors Volunteer to Not Stand for Re-Election at the Upcoming 2021 Annual Meeting of Stockholders
4 months ago | Business Wire

About:

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company develops levosimendan, which completed a phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction; and Imatinib, a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

9

Address:

Tenax Therapeutics, Inc. ONE Copley Parkway Suite 490 Morrisville NC 27560 United States

Website:

Home

Phone:

919-855-2100

Leave a comment

Your email address will not be published. Required fields are marked *